持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/02/21 | 7,750 | 7,790 | 7,710 | 7,730 | -60 | -0.8% | 18,400 |
| 2018/02/20 | 7,750 | 7,850 | 7,750 | 7,790 | +40 | +0.5% | 15,500 |
| 2018/02/19 | 7,700 | 7,810 | 7,700 | 7,750 | +130 | +1.7% | 15,600 |
| 2018/02/16 | 7,570 | 7,660 | 7,570 | 7,620 | +60 | +0.8% | 26,700 |
| 2018/02/15 | 7,590 | 7,660 | 7,550 | 7,560 | -30 | -0.4% | 20,000 |
| 2018/02/14 | 7,650 | 7,680 | 7,570 | 7,590 | -60 | -0.8% | 26,400 |
| 2018/02/13 | 7,780 | 7,850 | 7,630 | 7,650 | -80 | -1% | 28,700 |
| 2018/02/09 | 7,720 | 7,750 | 7,640 | 7,730 | -170 | -2.2% | 36,100 |
| 2018/02/08 | 7,940 | 8,000 | 7,880 | 7,900 | -20 | -0.3% | 28,900 |
| 2018/02/07 | 8,070 | 8,190 | 7,910 | 7,920 | +10 | +0.1% | 44,800 |
| 2018/02/06 | 8,200 | 8,200 | 7,810 | 7,910 | -420 | -5% | 57,100 |
| 2018/02/05 | 8,280 | 8,380 | 8,200 | 8,330 | -130 | -1.5% | 33,300 |
| 2018/02/02 | 8,330 | 8,510 | 8,320 | 8,460 | -10 | -0.1% | 20,200 |
| 2018/02/01 | 8,230 | 8,510 | 8,230 | 8,470 | +90 | +1.1% | 20,700 |
| 2018/01/31 | 8,430 | 8,560 | 8,370 | 8,380 | -100 | -1.2% | 34,500 |
| 2018/01/30 | 8,490 | 8,550 | 8,460 | 8,480 | -20 | -0.2% | 22,500 |
| 2018/01/29 | 8,550 | 8,610 | 8,500 | 8,500 | -90 | -1% | 12,000 |
| 2018/01/26 | 8,590 | 8,630 | 8,560 | 8,590 | +90 | +1.1% | 18,100 |
| 2018/01/25 | 8,550 | 8,600 | 8,490 | 8,500 | -70 | -0.8% | 19,200 |
| 2018/01/24 | 8,490 | 8,580 | 8,490 | 8,570 | +20 | +0.2% | 13,400 |
| 2018/01/23 | 8,530 | 8,610 | 8,530 | 8,550 | +10 | +0.1% | 16,300 |
| 2018/01/22 | 8,430 | 8,560 | 8,430 | 8,540 | -30 | -0.4% | 19,000 |
| 2018/01/19 | 8,590 | 8,680 | 8,560 | 8,570 | -80 | -0.9% | 13,400 |
| 2018/01/18 | 8,800 | 8,810 | 8,650 | 8,650 | -150 | -1.7% | 26,900 |
| 2018/01/17 | 8,920 | 8,920 | 8,780 | 8,800 | -90 | -1% | 19,900 |
| 2018/01/16 | 8,920 | 8,920 | 8,870 | 8,890 | -10 | -0.1% | 12,500 |
| 2018/01/15 | 8,880 | 8,930 | 8,830 | 8,900 | +70 | +0.8% | 13,000 |
| 2018/01/12 | 8,860 | 8,940 | 8,780 | 8,830 | -110 | -1.2% | 36,000 |
| 2018/01/11 | 8,890 | 8,950 | 8,860 | 8,940 | -20 | -0.2% | 19,700 |
| 2018/01/10 | 8,880 | 8,970 | 8,880 | 8,960 | +80 | +0.9% | 21,400 |
| 2018/01/09 | 8,850 | 8,880 | 8,790 | 8,880 | -10 | -0.1% | 33,400 |
| 2018/01/05 | 8,810 | 8,890 | 8,720 | 8,890 | +80 | +0.9% | 27,200 |
| 2018/01/04 | 8,710 | 8,810 | 8,700 | 8,810 | +180 | +2.1% | 19,200 |
| 2017/12/29 | 8,680 | 8,680 | 8,590 | 8,630 | -50 | -0.6% | 13,700 |
| 2017/12/28 | 8,780 | 8,790 | 8,650 | 8,680 | -100 | -1.1% | 16,300 |
| 2017/12/27 | 8,800 | 8,810 | 8,750 | 8,780 | +10 | +0.1% | 21,900 |
| 2017/12/26 | 8,740 | 8,780 | 8,700 | 8,770 | +100 | +1.2% | 23,300 |
| 2017/12/25 | 8,560 | 8,670 | 8,550 | 8,670 | +140 | +1.6% | 24,400 |
| 2017/12/22 | 8,480 | 8,530 | 8,430 | 8,530 | +60 | +0.7% | 29,100 |
| 2017/12/21 | 8,360 | 8,490 | 8,330 | 8,470 | +90 | +1.1% | 25,400 |
| 2017/12/20 | 8,290 | 8,410 | 8,290 | 8,380 | ±0 | ±0% | 13,000 |
| 2017/12/19 | 8,400 | 8,400 | 8,340 | 8,380 | -10 | -0.1% | 17,700 |
| 2017/12/18 | 8,380 | 8,410 | 8,330 | 8,390 | +70 | +0.8% | 20,500 |
| 2017/12/15 | 8,290 | 8,350 | 8,230 | 8,320 | +50 | +0.6% | 26,800 |
| 2017/12/14 | 8,300 | 8,380 | 8,200 | 8,270 | -10 | -0.1% | 37,000 |
| 2017/12/13 | 8,190 | 8,290 | 8,190 | 8,280 | +80 | +1% | 21,800 |
| 2017/12/12 | 8,170 | 8,230 | 8,150 | 8,200 | +40 | +0.5% | 18,400 |
| 2017/12/11 | 8,250 | 8,250 | 8,120 | 8,160 | -40 | -0.5% | 21,200 |
| 2017/12/08 | 8,040 | 8,290 | 8,040 | 8,200 | +10 | +0.1% | 48,800 |
| 2017/12/07 | 8,160 | 8,210 | 8,150 | 8,190 | +100 | +1.2% | 16,900 |
1651～
1700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
